Abion Inc: Clinical Trials

3 trials sponsored by Abion Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Recruiting 1

Follow Abion Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
Vabametkib, Lazertinib - Advanced Solid Tumors
Phase 2RecruitingAbion Inc1782023-01-172025-05-22
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers
High-fat meal (over 900 kcal), ABN401 (investigational product) - Solid Tumor
Phase 1CompletedAbion Inc252022-01-042024-02-20
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
ABN401- Escalation Phase, ABN401- Expansion Phase - Advanced Solid Tumors
Phase 1CompletedAbion Inc242019-08-012025-01-06

Interventions

lazertinib (1)

Countries

South Korea (3)  ·  Australia (1)  ·  Taiwan (1)  ·  United States (1)

Results publications

PMID 41927036